PCMU
GILD icon

Paragon Capital Management (Utah)’s Gilead Sciences GILD Stock Holding History

Paragon Capital Management (Utah)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,991
Closed -$1.16M – 71
2023
Q2 		$1.16M Sell
14,991
-6,646
-31% -$530K 0.98% 42
2023
Q1 		$1.8M Buy
21,637
+7,662
+55% +$635K 1.56% 15
2022
Q4 		$1.2M Buy
+13,975
New +$1.11M 1.12% 25

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Paragon Capital Management (Utah)'s GILD Position: Q3 2023 in Review

Paragon Capital Management (Utah) sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 14,991 shares — an estimated $1.16M sold.

Paragon Capital Management (Utah) first reported a position in GILD in Q4 2022 and held it in 3 quarters. The position peaked at $1.8M in Q1 2023. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Paragon Capital Management (Utah) reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 14,991 Gilead Sciences shares in Q3 2023, an estimated $1.16M.
  • Paragon Capital Management (Utah) first reported a position in Gilead Sciences in Q4 2022 and held it in 3 quarters.
  • Paragon Capital Management (Utah)'s Gilead Sciences position peaked at $1.8M in Q1 2023.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Paragon Capital Management (Utah)'s 13F filing for Q3 2023, filed 26 Sep 2024.